The scientist’s investigation covers issues in COPD, Internal medicine, Asthma, Physical therapy and Immunology. He combines subjects such as Respiratory disease, Pulmonary disease, Intensive care medicine, Disease and Spirometry with his study of COPD. His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology, Placebo, Endocrinology and Sputum.
His Asthma study incorporates themes from Global health, Health care and Family medicine. The study incorporates disciplines such as Prospective cohort study, Clinical trial, Severity of illness and MEDLINE in addition to Physical therapy. In his work, Chlamydia, Pneumonia, Serology, Bronchial hyperreactivity and Asthma copd overlap is strongly intertwined with Airway obstruction, which is a subfield of Immunology.
Klaus F. Rabe focuses on Internal medicine, COPD, Asthma, Immunology and Intensive care medicine. His work investigates the relationship between Internal medicine and topics such as Placebo that intersect with problems in Randomized controlled trial. His study looks at the relationship between COPD and fields such as Anesthesia, as well as how they intersect with chemical problems.
His work in the fields of Asthma, such as Dupilumab, intersects with other areas such as In patient. His Immunology research includes elements of Sputum and Lung. Klaus F. Rabe has included themes like Disease and MEDLINE in his Intensive care medicine study.
Internal medicine, Asthma, COPD, Budesonide and Metered-dose inhaler are his primary areas of study. His studies deal with areas such as Gastroenterology and Placebo as well as Internal medicine. Asthma is the subject of his research, which falls under Immunology.
He interconnects Megakaryocyte and breakpoint cluster region in the investigation of issues within Immunology. His Obstructive lung disease study, which is part of a larger body of work in COPD, is frequently linked to Tumor necrosis factor receptor 2, bridging the gap between disciplines. Within one scientific family, Klaus F. Rabe focuses on topics pertaining to Glycopyrrolate under Budesonide, and may sometimes address concerns connected to Formoterol Fumarate and Pulmonary disease.
Klaus F. Rabe spends much of his time researching Internal medicine, Asthma, COPD, Placebo and Dupilumab. His Internal medicine study frequently links to related topics such as Gastroenterology. His Asthma research incorporates themes from Body mass index, Vital capacity, microRNA, Cell biology and Cohort.
His COPD research includes themes of Exacerbation, Metered-dose inhaler, Bronchodilator and Hazard ratio. In his study, which falls under the umbrella issue of Dupilumab, Corticosteroid, Airway obstruction and Exhaled nitric oxide is strongly linked to FEV1/FVC ratio. His work deals with themes such as Glucocorticoid, Inhalation, Randomized controlled trial and Muscarinic antagonist, which intersect with Pulmonary disease.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs
J. Bousquet;H. J. Schünemann;B. Samolinski;P. Demoly.
The Journal of Allergy and Clinical Immunology (2012)
Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)
J. Bousquet;N. Khaltaev;A. A. Cruz;J. Denburg.
Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study
KF Rabe;PA Vermeire;JB Soriano;WC Maier.
European Respiratory Journal (2000)
Chronic obstructive pulmonary disease phenotypes: the future of COPD.
Mei Lan K. Han;Alvar Agusti;Peter M. Calverley;Bartolome R. Celli.
American Journal of Respiratory and Critical Care Medicine (2010)
Burden and clinical features of chronic obstructive pulmonary disease (COPD).
Romain A Pauwels;Klaus F Rabe.
The Lancet (2004)
WORLDWIDE SEVERITY AND CONTROL OF ASTHMA IN CHILDREN AND ADULTS : THE GLOBAL ASTHMA INSIGHTS AND REALITY SURVEYS
Klaus F Rabe;Mitsuru Adachi;Christopher K.W Lai;Joan B Soriano.
The Journal of Allergy and Clinical Immunology (2004)
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
Mario Castro;Jonathan Corren;Ian D. Pavord;Jorge Maspero.
The New England Journal of Medicine (2018)
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials
Peter M A Calverley;Klaus F Rabe;Udo-Michael Goehring;Søren Kristiansen.
The Lancet (2009)
Outcomes for COPD pharmacological trials: From lung function to biomarkers
M. Cazzola;W. MacNee;F.J. Martinez;K.F. Rabe.
European Respiratory Journal (2008)
Complex chronic comorbidities of COPD
L M Fabbri;F Luppi;B Beghé;K F Rabe.
European Respiratory Journal (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: